A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands - Ligand-induced serpin polymerization

被引:63
作者
Egelund, R
Einholm, AP
Pedersen, KE
Nielsen, RW
Christensen, A
Deinum, J
Andreasen, PA
机构
[1] Aarhus Univ, Dept Mol & Struct Biol, Lab Cellular Prot Sci, DK-8000 Aarhus C, Denmark
[2] Astra Zeneca, R&D Molndal, S-43183 Molndal, Sweden
关键词
D O I
10.1074/jbc.M009024200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have characterized the neutralization of the inhibitory activity of the serpin plasminogen activator inhibitor-1 (PAI-1) by a number of structurally distinct organo-chemicals, including compounds with environment-sensitive spectroscopic properties. In contrast to latent and reactive center-cleaved PAI-1 and PAI-1 in complex with urokinase-type plasminogen activator (uPA), active PAI-1 strongly increased the fluorescence of the PAI-1-neutralizing compounds 1-anilinonaphthalene-8-sulfonic acid and 4,4'-dianilino-1,1'-bisnaphthyl-5,5'-dis acid, The fluorescence increase could be competed by all tested nonfluorescent neutralizers, indicating that all neutralizers bind to a common hydrophobic area preferentially accessible in active PAI-1, Activity neutralization proceeded through two consecutive steps as follows: first step is conversion to forms displaying substrate behavior toward uPA, and second step is to forms inert to uPA With some neutralizers, the second step was associated with PAI-1 polymerization, Vitronectin reduced the susceptibility to the neutralizers. Changes in sensitivity to activity neutralization by point mutations were compatible with the various neutralizers having overlapping but not identical, binding sites in the region around alpha -helices D and E and beta -strand 1A, known to act as a flexible joint when beta -sheet A opens and the reactive center loop inserts as beta -strand 4A during reaction with target proteinases. The defined binding area may be a target for development of compounds for neutralizing PAI-1 in cancer and cardiovascular diseases.
引用
收藏
页码:13077 / 13086
页数:10
相关论文
共 72 条
[1]   MECHANISMS CONTRIBUTING TO THE CONFORMATIONAL AND FUNCTIONAL FLEXIBILITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
AERTGEERTS, K ;
DEBONDT, HL ;
DERANTER, CJ ;
DECLERCK, PJ .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (10) :891-897
[2]  
Andreasen PA, 1999, THROMB HAEMOSTASIS, V81, P407
[3]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[4]  
Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO
[5]  
2-Z
[6]   The plasminogen activation system in tumor growth, invasion, and metastasis [J].
Andreasen, PA ;
Egelund, R ;
Petersen, HH .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (01) :25-40
[7]   Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization [J].
Bajou, K ;
Noël, A ;
Gerard, RD ;
Masson, V ;
Brunner, N ;
Holst-Hansen, C ;
Skobe, M ;
Fusenig, NE ;
Carmeliet, P ;
Collen, D ;
Foidart, JM .
NATURE MEDICINE, 1998, 4 (08) :923-928
[8]   Identification of the binding site for a low-molecular-weight inhibitor of plasminogen activator inhibitor type 1 by site-directed mutagenesis [J].
Björquist, P ;
Ehnebom, J ;
Inghardt, T ;
Hansson, L ;
Lindberg, M ;
Linschoten, M ;
Strömqvist, M ;
Deinum, J .
BIOCHEMISTRY, 1998, 37 (05) :1227-1234
[9]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[10]   ANALYSIS OF PROTEIN AND PEPTIDE MIXTURES - EVALUATION OF 3 SODIUM DODECYL SULFATE-POLYACRYLAMIDE GEL-ELECTROPHORESIS BUFFER SYSTEMS [J].
BURY, AF .
JOURNAL OF CHROMATOGRAPHY, 1981, 213 (03) :491-500